|
| |
Overview
Financial Highlight
HeadlinesBusiness Background Ho Wah Genting Bhd is an investment holding company. It is engaged in the provision of management services. The company's segments include Investment, Moulded power supply cord sets, Wires and cables, Automotive, Mining, Travelling services and Direct selling. The Investment segment includes investment in properties and investment by the holding company. The Moulded power supply cord sets segment is engaged in manufacturing and trading of wires and cables; molded power supply cord sets and cable assemblies for electrical and electronic devices and equipment. The Wires and cables segment is engaged in trading of wires and cables. The Automotive segment is engaged in trading of motor vehicles.
  Calvinharris BREAKING NEWS OF VACCINE!!! JUST IN TODAY AFTERNOON!!! https://www.theedgemarkets.com/article/china-coronavirus-vaccine-may-be-ready-public-november STAY BUY!!! 15/09/2020 4:13 PM bojed Meh, quite underwhelming. Maybe many people sell because tomorrow is a public holiday. 15/09/2020 4:52 PM longtermvaluegain 中国疾病预防控制中心（CDC）的一位官员说，中国正在开发的冠状病毒疫苗最早可以在11月投入使用。 在临床试验的最后阶段，中国有四种Covid-19疫苗。根据7月份启动的紧急使用计划，其中至少有三项已经提供给基本工人。 疾病预防控制中心首席生物安全专家吴桂珍在周一晚间接受国家电视台采访时说，三期临床试验进展顺利，疫苗有望在11月或12月面向公众使用。 吴说，她在四月份自己服用了实验性疫苗后最近几个月没有出现异常症状，她没有具体说明她指的是哪种疫苗。 国家制药巨头中国国家医药集团（Sinopharm）和在美国上市的Sinovac Biotech的一个部门正在根据该州的紧急使用计划开发这三种疫苗。 CanSino Biologics正在研发的第四种Covid-19疫苗已于6月获中国军方批准使用。 国药控股在七月表示，在第三阶段试验结束后，其疫苗可在今年年底前准备好供公众使用。 全球疫苗生产商正在争相开发一种有效的针对这种病毒的疫苗，该疫苗已经杀死了925,000多人。西方领先的疫苗生产商在本月初承诺要坚持科学研究标准，并拒绝任何催促该过程的政治压力. 15/09/2020 6:58 PM Williamtaychunkit https://www.sinchew.com.my/pad/con/content_2343469.html?fbclid=IwAR0FeldUTmS1Be4QU45p96Gas1RHbyJ0LbF-_suY8JNBwOX2u3_zazxwt3k 早知先握紧紧Hwgb. 16/09/2020 12:03 PM Williamtaychunkit https://www.sinchew.com.my/pad/con/content_2343469.html?fbclid=IwAR0FeldUTmS1Be4QU45p96Gas1RHbyJ0LbF-_suY8JNBwOX2u3_zazxwt3k 16/09/2020 12:04 PM Calvinharris Ho Wah Genting Bhd, which has jumped on the Covid-19 bandwagon, is considering appointing Xinkexian (Beijing) Biotechnology Co, Ltd (XKX) as its nonexclusive manufacturer to produce Covid-19 vaccines. Its wholly-owned subsidiary HWGB Biotech Sdn Bhd has entered into a Memorandum of Understanding with Xinkexian (Beijing) Biotechnology Co, Ltd (XKX) for a possible partnership. (The Edge) 16/09/2020 1:13 PM bojed https://www.forbes.com/sites/jackbrewster/2020/09/15/trump-says-vaccine-will-be-ready-in-as-little-as-four-weeks---scientists-say-thats-aggressive/amp/ Want to take a guess the theme for this week? Haha 16/09/2020 2:18 PM Friendship If you want to buy vaccine play, biggest hidden Gem is Titijaya as it has Formal Agreement with Sinopharm the leading candidate for Covid19 Vaccine! Please choose the right one 16/09/2020 2:33 PM bojed http://uk.investing.com/analysis/could-astrazeneca-shares-be-on-the-way-to-new-highs-200446778 And the theme for this week would be.... LOL! 16/09/2020 6:32 PM JasonJy https://www.scmp.com/news/china/science/article/3101709/there-wont-be-enough-coronavirus-vaccines-return-normal-life 16/09/2020 10:14 PM Calvinharris https://www.wsj.com/articles/in-global-covid-19-vaccine-race-chinese-shot-receives-first-foreign-approval-11600171149 在全球Covid-19疫苗比赛中，中国注射剂获得了首个国外批准!!! 17/09/2020 5:45 AM azee https://klse.i3investor.com/blogs/tradeviewe/2020-09-14-story-h1513492095-MLAB_enters_healthcare_business_for_growth.jsp 17/09/2020 9:25 AM moneymoneycome longtermvaluegain, HWGB been up a lot and now drop a lot. Hopefully it is not a pump and dump counter 17/09/2020 11:30 AM humongainz @moneymoneycome What if I tell you it is. The signs not clear enough? 17/09/2020 11:30 AM nuilam hali China Expects Virus Vaccine to Be Ready in November, Expert Says Bloomberg News 17/09/2020 8:07 PM zacklee95 bear engulfing. I just cut. See more downside than upside. Goodluck guys :) 17/09/2020 8:43 PM Ram Mail limit up Monday... https://www.theedgemarkets.com/article/hwgb-biotech-enters-covid19-vaccine-rd-agreements 19/09/2020 12:19 AM menort "High percentage of retailer who think they can out-smart the stock market and enter lose making penny stock and dream to become a millionaire, majority will lose big amount of money compare to the retailer who put money on profit making company that its share price Rm1 and above counter" Want to go vaccine counter? go to genuine vaccine counter example Pharmaniaga and Duopharma. Malaysia gave licence only to Pharmaniaga and Duopharma to distribute covid19. Dont act smart and think counter like Bintai,Hwgb,Mqtech etc can sell vaccine it will never happen in Million years in Malaysia. Never touch any lose making penny stock counter who try to ride on vaccine theme. Want to invest on glove counter? invest only on genuine glove counter Top glove, Supermax, Hartalega, Kossan, Ruberex, Comfort, Careplus, Hlt and LKL. Retailer need to be smart now and dont let syndicate pull your leg. 20/09/2020 1:42 AM nuilam hali HWGB Biotech enters into COVID-19 vaccine R&D agreements menort is it fake 20/09/2020 6:16 AM Hunter8888 don't worry be happy.just follow director buying...maybe lose company making profit company future hahaha..many people say don't buy.but price still stabil and up....come to me rm2 baby.kahkahkah. 20/09/2020 7:45 AM Ram Mail Yes agreed with menort. But if we flash back last time glove counter such as HLT, Care+, LKL, etc also like penny stock. If u realise currently all that counter be the selected and famous counter. Same goes to vaccine counter later on.. as long as make money. 20/09/2020 11:21 AM Despacito Aduhai...kesal jual hari Jumaat lalu @0.72...huhuhu Besok kalau operator bagi jual sama gua pada limit-up @1.02 pun kira nasib lah...sudah terbulus baharu melantai!!! 20/09/2020 12:15 PM Boneka HWGB WILL BENEFIT ENORMOUSLY FROM EBI'S RECENT “PHASE IV” CLINICAL TRIAL. THIS HAS PLACED EBI AHEAD OF ITS COMPETITORS WHICH ARE NOW AT “PHASE III” ONLY. On 13th Sept 2020, EBI has engaged the services of Roderick A. Comunale II MD Inc (Principal Investigator) to conduct a clinical research study entitled “Inactivated Polio Vaccine in prevention of COVID-19 in high risk population in a Phase IV study, which shall study the effects of Inactive Polio Vaccine-IPV which shall be conducted according to the US Food and Drug Administration approved protocol and to be provided by EBI. 1) COVID-19 VACCINE TRACKER Globally, researchers are testing 40 vaccines in clinical trials on humans, and at least 92 preclinical vaccines are under active investigation in animals. China is conducting clinical trials of 11 COVID-19 vaccines, 4 of which have entered Phase III trials, said Wang Zhigang, Chinese minister of Science and Technology, at the Global Science and Life Health Forum in Beijing on Friday (18th Sept 2020). 2) UNDERSTANDING THE 5 PHASES OF CLINICAL TRIALS https://en.m.wikipedia.org/wiki/Clinical_trial#Phases Clinical trials involving new drugs are commonly classified into five phases. Each phase of the drug approval process is treated as a separate clinical trial. The drug development process will normally proceed through phases I to IV over many years, frequently involving a decade or longer. If the drug successfully passes through phases I, II, and III, it will usually be approved by the national regulatory authority for use in the general population. Phase IV trials are performed after the newly approved drug, diagnostic or device is marketed, providing assessment about risks, benefits, or best uses. ---> This refers to EBI’s Phase IV study; 3) UNDERTANDING THE TECHNICAL ROUTE FOR VACCINE DEVELOPMENT Vaccine development usually adopts five technical routes worldwide, namely inactivated vaccines, recombinant protein vaccines, attenuated influenza virus vaccines, adenoviral vector vaccines, and nucleic acid vaccines (mRNA, DNA). (i) The inactivated vaccine is the most common approach. Its features are simple, rapid development, high safety, and usually used to deal with acute diseases. ---> This refers to EBI’s “Inactivated Polio Vaccine in prevention of COVID-19 in high risk population in a Phase IV study; (ii) Adenovirus vector vaccine is made by using harmless modified adenovirus as a carrier and loaded into the virus' spike protein gene to stimulate the production of antibodies in the human body. It is safe, efficient, and causes few adverse reactions. 4) CONCLUSION On 9th Sept 2020, Bursa announced that HWGB BIOTECH SDB BHD had earmarked its production facilities by appointing XKX as a non-exclusive manufacture to produce vaccine. XKX has the production facilities and is able to manufacture poliomyelitis vaccines, including different strains and formulation and dosage form systems of oral poliovirus (OPV), Oral Poliovirus (liquid) (OPVL) and Inactivated Poliovirus Vaccine (IPV) (“Polio Vaccines”) and the new indication which proposes the use of existing Polio Vaccines for prevention of COVID-19 virus (collectively “Vaccines”). This was the last piece of the jigsaw puzzle to complete HWGB Biotech Sdn Bhd’s production & sales setup for EBI’s vaccine. Should one invest in this vaccine production company now? You’ll be your own judge! [DISCLAIMER – TAYOR] © ATH https://ibb.co/n0tLMjj 20/09/2020 4:56 PM malysiabolehhh https://www.nst.com.my/business/2020/09/625880/ho-wah-genting-inks-3-agreements-covid-19-vaccine-study Not 1 but 3! Going strong! 21/09/2020 11:55 AM nuilam hali value shares are a better way to bet on a Covid-19 vaccine than cyclical stocks, even though the latter have gained favor for capturing the trade, according to Goldman Sachs Group Inc. Value shares beat their growth counterparts by more than 3 percentage points over the Aug. 22 to Sept. 8 period, when the chances of a vaccine available by the first quarter of 2021 jumped to about 70% from around 40%, Goldman strategists led by David Kostin wrote in a note Friday. Cyclical shares underperformed defensive ones, they said. 21/09/2020 8:20 PM  | |
